Literature DB >> 23574322

T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.

S Russi1, G Lauletta, G Serviddio, S Sansonno, V Conteduca, L Sansonno, V De Re, D Sansonno.   

Abstract

To characterize the repertoire of T lymphocytes in chronically hepatitis C virus (HCV)-infected patients with and without mixed cryoglobulinaemia (MC). T cell receptor (TCR) variable (V) β clonalities in portal tracts isolated from liver biopsy sections with a laser capture microdissection technique in 30 HCV-positive MC patients were studied by size spectratyping. Complementarity-determining region 3 (CDR3) profiles of liver-infiltrating lymphocytes (LIL) were also compared with those circulating in the blood. The representative results of TCR Vβ by CDR3 were also obtained from liver tissues and peripheral blood lymphocytes (PBL) of 21 chronically HCV-infected patients without MC. LIL were highly restricted, with evidence of TCR Vβ clonotypic expansions in 23 of 30 (77%) and in 15 of 21 (71%) MC and non-MC patients, respectively. The blood compartment contained TCR Vβ expanded clones in 19 (63%) MC and 12 (57%) non-MC patients. The occurrence of LIL clonalities was detected irrespective of the degree of liver damage or circulating viral load, whereas it correlated positively with higher levels of intrahepatic HCV RNA. These results support the notion that TCR Vβ repertoire is clonally expanded in HCV-related MC with features comparable to those found in chronically HCV-infected patients without MC.
© 2012 British Society for Immunology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574322      PMCID: PMC3628328          DOI: 10.1111/cei.12035

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

Review 1.  Retroviral reverse transcription and integration: progress and problems.

Authors:  J M Whitcomb; S H Hughes
Journal:  Annu Rev Cell Biol       Date:  1992

2.  A comparison of multiplex and monoplex T-cell receptor gamma PCR.

Authors:  Bonnie Shadrach; Ilka Warshawsky
Journal:  Diagn Mol Pathol       Date:  2004-09

3.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

4.  Many different Vbeta CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions.

Authors:  Kira Rubtsova; James P Scott-Browne; Frances Crawford; Shaodong Dai; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-28       Impact factor: 11.205

5.  Antigen-driven patterns of TCR bias are shared across diverse outcomes of human hepatitis C virus infection.

Authors:  John J Miles; Duangtawan Thammanichanond; Sarah Moneer; Usha K Nivarthi; Lars Kjer-Nielsen; Samantha L Tracy; Campbell K Aitken; Rebekah M Brennan; Weiguang Zeng; Louise Marquart; David Jackson; Scott R Burrows; David S Bowden; Joseph Torresi; Margaret Hellard; Jamie Rossjohn; James McCluskey; Mandvi Bharadwaj
Journal:  J Immunol       Date:  2010-12-15       Impact factor: 5.422

Review 6.  Success and failure of virus-specific T cell responses in hepatitis C virus infection.

Authors:  Christoph Neumann-Haefelin; Robert Thimme
Journal:  Dig Dis       Date:  2011-08-30       Impact factor: 2.404

Review 7.  The molecular basis of TCR germline bias for MHC is surprisingly simple.

Authors:  K Christopher Garcia; Jarrett J Adams; Dan Feng; Lauren K Ely
Journal:  Nat Immunol       Date:  2009-02       Impact factor: 25.606

8.  The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study.

Authors:  J F Mosnier; C Degott; P Marcellin; D Hénin; S Erlinger; J P Benhamou
Journal:  Hepatology       Date:  1993-03       Impact factor: 17.425

9.  Longitudinal system-based analysis of transcriptional responses to type I interferons.

Authors:  D J Pappas; G Coppola; P A Gabatto; F Gao; D H Geschwind; J R Oksenberg; S E Baranzini
Journal:  Physiol Genomics       Date:  2009-06-16       Impact factor: 3.107

Review 10.  Hepatitis C virus infection and mixed cryoglobulinemia.

Authors:  Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno
Journal:  Clin Dev Immunol       Date:  2012-07-10
View more
  5 in total

1.  Efficient Culture of Human Naive and Memory B Cells for Use as APCs.

Authors:  Kuei-Ying Su; Akiko Watanabe; Chen-Hao Yeh; Garnett Kelsoe; Masayuki Kuraoka
Journal:  J Immunol       Date:  2016-10-10       Impact factor: 5.422

2.  Abnormal CD4 + T helper (Th) 1 cells and activated memory B cells are associated with type III asymptomatic mixed cryoglobulinemia in HCV infection.

Authors:  Fanyun Kong; Wei Zhang; Bo Feng; Henghui Zhang; Huiying Rao; Jianghua Wang; Xu Cong; Lai Wei
Journal:  Virol J       Date:  2015-07-01       Impact factor: 4.099

3.  Assessment of total hepatitis C virus (HCV) core protein in HCV-related mixed cryoglobulinemia.

Authors:  Sabino Russi; Domenico Sansonno; Maria Addolorata Mariggiò; Angela Vinella; Fabio Pavone; Gianfranco Lauletta; Silvia Sansonno; Franco Dammacco
Journal:  Arthritis Res Ther       Date:  2014-03-18       Impact factor: 5.156

4.  Specificity, Privacy, and Degeneracy in the CD4 T Cell Receptor Repertoire Following Immunization.

Authors:  Yuxin Sun; Katharine Best; Mattia Cinelli; James M Heather; Shlomit Reich-Zeliger; Eric Shifrut; Nir Friedman; John Shawe-Taylor; Benny Chain
Journal:  Front Immunol       Date:  2017-04-13       Impact factor: 7.561

5.  Tracking global changes induced in the CD4 T-cell receptor repertoire by immunization with a complex antigen using short stretches of CDR3 protein sequence.

Authors:  Niclas Thomas; Katharine Best; Mattia Cinelli; Shlomit Reich-Zeliger; Hilah Gal; Eric Shifrut; Asaf Madi; Nir Friedman; John Shawe-Taylor; Benny Chain
Journal:  Bioinformatics       Date:  2014-08-05       Impact factor: 6.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.